You have 9 free searches left this month | for more free features.

golimumab

Showing 1 - 25 of 42

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Psoriatic Arthritis Trial in Philadelphia (Guselkumab, Golimumab)

Not yet recruiting
  • Psoriatic Arthritis
  • Philadelphia, Pennsylvania
    University of Pennsylvania
Nov 18, 2022

Psoriatic Arthritis Trial in Philadelphia (Guselkumab, Golimumab, Placebo)

Not yet recruiting
  • Psoriatic Arthritis
  • Philadelphia, Pennsylvania
    Hospital at the University of Pennsylvania
Dec 20, 2022

Axial Spondyloarthritis Trial in Bonheiden, Ghent, Hasselt (Golimumab)

Recruiting
  • Axial Spondyloarthritis
  • Golimumab
  • Bonheiden, Antwerpen, Belgium
  • +2 more
Nov 30, 2022

Diabetes, Type 1 Trial in San Diego (Golimumab)

Available
  • Diabetes Mellitus, Type 1
  • Golimumab
  • San Diego, California
    Rady Children's Hospital
Jul 28, 2022

Castration-Resistant Prostate Carcinoma, Prostate Adenocarcinoma Trial in Seattle (Apalutamide, Biopsy, Biospecimen Collection)

Not yet recruiting
  • Castration-Resistant Prostate Carcinoma
  • Prostate Adenocarcinoma
  • Seattle, Washington
    Fred Hutch/University of Washington Cancer Consortium
Jul 20, 2023

Arthritis, Juvenile Trial in Worldwide (Golimumab, Methotrexate)

Active, not recruiting
  • Arthritis, Juvenile
  • San Diego, California
  • +37 more
Jan 17, 2023

Golimumab in Juvenile Idiopathic Arthritis-associated Uveitis

Completed
  • JIA Associated Uveitis
  • Golimumab
  • (no location specified)
Sep 1, 2021

Type 1 Diabetes Trial in Idaho Falls, Seattle (Liraglutide, Golimumab)

Completed
  • Type 1 Diabetes Mellitus
  • Idaho Falls, Idaho
  • +1 more
Jan 21, 2022

Modulation of Gut Microbiota in Ulcerative Colitis

Completed
  • Ulcerative Colitis
  • Golimumab
  • Girona, Catalonia, Spain
    Hospital Doctor Josep Trueta
Jun 28, 2021

Ulcerative Colitis Trial in London (Golimumab)

Completed
  • Ulcerative Colitis
  • Golimumab
  • London, United Kingdom
    Guy's & St Thomas' NHS Foundation Trust
Jul 2, 2021

Pre-Symptomatic Type 1 Diabetes Trial in Finland, Sweden, United States (Golimumab, Placebo)

Completed
  • Pre-Symptomatic Type 1 Diabetes
  • Golimumab
  • Placebo
  • Aurora, Colorado
  • +7 more
Sep 9, 2021

ULCERATIVE COLITIS Trial in Belgium, France (GOLIMUMAB)

Active, not recruiting
  • ULCERATIVE COLITIS
  • GOLIMUMAB
  • Liege, Belgium
  • +22 more
Jun 28, 2021

Diabetes, Type 1 Trial (Golimumab, Placebo)

Withdrawn
  • Diabetes Mellitus, Type 1
  • Golimumab
  • Placebo
  • (no location specified)
Nov 19, 2021

Psoriatic Arthritis, Withdrawal, Reduction Trial in Erlangen (Prednisolone, Sulfasalazine, Leflunomide)

Recruiting
  • Psoriatic Arthritis
  • +2 more
  • Erlangen, Bavaria, Germany
    Universitätsklinikum Erlangen
Nov 10, 2022

Colitis, Ulcerative Trial in Worldwide (Golimumab, Infliximab)

Recruiting
  • Colitis, Ulcerative
  • San Francisco, California
  • +64 more
Aug 17, 2022

Rheumatoid Arthritis Trial in Omaha (Methotrexate, Abatacept, Adalimumab)

Recruiting
  • Rheumatoid Arthritis
  • Omaha, Nebraska
    University of Nebraska Medical Center
Oct 28, 2021

Arthritis, Psoriatic Trial in Worldwide (Guselkumab, Golimumab, Placebo)

Recruiting
  • Arthritis, Psoriatic
  • Phoenix, Arizona
  • +96 more
Jan 17, 2023

Hepatosplenic T-Cell Lymphoma Trial in Norfolk (Infliximab, Golimumab)

Completed
  • Hepatosplenic T-Cell Lymphoma
  • Norfolk, Virginia
    (unnamed)
Feb 12, 2021

Effectiveness and Adherence of Golimumab in Rheumatoid Arthritis

Unknown status
  • Arthritis, Rheumatoid
  • Golimumab
  • Beijing, Beijing, China
    Peking Union Medical College Hospital
Dec 3, 2019

Crohn's Disease Trial in Worldwide (Guselkumab, Golimumab, JNJ-78934804)

Not yet recruiting
  • Crohn's Disease
  • Guselkumab
  • +3 more
  • Birmingham, Alabama
  • +167 more
Jul 14, 2022

(CHOIR)

Recruiting
  • Chronic Nonbacterial Osteomyelitis
  • Chronic Recurrent Multifocal Osteomyelitis
  • Seattle, Washington
    Seattle Children's Hospital
Jan 25, 2021

Ankylosing Spondylitis Trial in Germany (Golimumab, Celecoxib)

Completed
  • Ankylosing Spondylitis
  • Altenburg, Germany
  • +18 more
Jan 26, 2021

Colitis, Ulcerative Trial in Worldwide (Guselkumab, Golimumab, JNJ-78934804)

Not yet recruiting
  • Colitis, Ulcerative
  • Guselkumab
  • +3 more
  • Arcadia, California
  • +236 more
Jul 14, 2022

Psoriatic Arthritis Trial in Leeds (Golimumab, Methotrexate)

Unknown status
  • Psoriatic Arthritis
  • Leeds, West Yorkshire, United Kingdom
    The Leeds Teaching Hospitals NHS Trust
Sep 27, 2019

Peripheral Spondylarthritis Trial in Ghent (Placebo, Golimumab)

Completed
  • Peripheral Spondylarthritis
  • Placebo
  • Golimumab
  • Ghent, Belgium
    Ghent University Hospital
May 28, 2019